Fortress Biotech Net Debt Growth & History (FBIO)

Fortress Biotech's net debt was −$10.1M for fiscal 2025.

View full Fortress Biotech company overview

Fortress Biotech annual net debt history

Fortress Biotech annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$10.1M−$28.2M
20242024-12-31$18.1M$17.3M+2362.13%
20232023-12-31$734,000$63.3M
20222022-12-31−$62.5M$177.2M
20212021-12-31−$239.7M−$29.5M
20202020-12-31−$210.3M−$182.7M
20192019-12-31−$27.5M−$46.4M
20182018-12-31$18.9M$46.3M
20172017-12-31−$27.4M$47.6M
20162016-12-31−$75.0M−$787,000
20152015-12-31−$74.2M−$38.4M
20142014-12-31−$35.8M

Fortress Biotech net debt trends

Over the last five fiscal years, Fortress Biotech's net debt increased from −$210.3M to −$10.1M, a change of $200.2M. The latest reported quarter, Q2 2026, shows −$147.9M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Fortress Biotech source filings ↗

Community posts

It’s quiet here.

No posts about FBIO yet. Start the conversation.

Write the first post